Drug Co. InvaTech Says Loan Terms Pushed It Into Ch. 11
InvaTech Pharma Solutions LLC, a New Jersey-based developer of generic prescription drugs, chose to enter Chapter 11 with up to $50 million in debt in part because some of its secured...To view the full article, register now.
Already a subscriber? Click here to view full article